Valeant Announces News, Hits 52-Week High

Valeant Pharmaceuticals International Inc. (T.VRX) reached a new 52-week high of $35.13 Tuesday. Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant announced the introduction of Ocuvite® Blue Light eye vitamins, a nutritional supplement formulated with lutein and zeaxanthin, the two carotenoid pigments naturally found in the eye. This formulation of eye nutrients includes high levels of lutein and helps protect eyes from the blue light that reaches the macula, which is responsible for our central vision.

Yellow Pages Limited (T.Y) reached a new 52-week high of $10.09 Tuesday. No news announcements today

TMX Group Limited (T.X) reached a new 52-week high of $85.53 Tuesday. No news announcements today

Aptose Biosciences Inc. (T.APS) reached a new 52-week high of $5.69 Tuesday. No news announcements today

CAE Inc. (T.CAE) reached a new 52-week high of $27.85 Tuesday. No news announcements today

TFI International Inc. (T.TFII) reached a new 52-week high of $41.58 Tuesday. No news announcements today

Canadian Pacific Railway Limited (T.CP) reached a new 52-week high of $253.34 Tuesday. No news announcements today

Dream Hard Asset Alternatives Trust (T.DRA.UN) reached a new 52-week high of $6.85 Tuesday. No news announcements today

Symbility Solutions Inc (V.SY) reached a new 52-week high of 57 cents Tuesday. No news announcements today

FirstService Corporation (T.FSV) reached a new 52-week high of $95.61 Tuesday. No news announcements today